These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34923204)

  • 41. Do patients discussed at a lung cancer multidisciplinary team meeting receive guideline-recommended treatment?
    Boxer MM; Duggan KJ; Descallar J; Vinod SK
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):52-60. PubMed ID: 26481765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival - a registry-based study.
    Rollet Q; Bouvier V; Moutel G; Launay L; Bignon AL; Bouhier-Leporrier K; Launoy G; Lièvre A
    BMC Health Serv Res; 2021 Oct; 21(1):1032. PubMed ID: 34592971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.
    Beckett P; Tata LJ; Hubbard RB
    Lung Cancer; 2014 Mar; 83(3):396-400. PubMed ID: 24457105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey.
    Teoh AKY; Holland AE; Morisset J; Flaherty KR; Wells AU; Walsh SLF; Glaspole I; Wuyts WA; Corte TJ;
    Ann Am Thorac Soc; 2022 Jan; 19(1):66-73. PubMed ID: 34191689
    [No Abstract]   [Full Text] [Related]  

  • 45. Application of Guideline Recommended Treatment in Routine Clinical Practice: A Population-based Study of Stage I-IIIB Non-small Cell Lung Cancer.
    Duggan KJ; Descallar J; Vinod SK
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):639-47. PubMed ID: 27211609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer: A matched retrospective cohort study in a French area.
    Reboux N; Cadieu E; Pruvost-Couvreur M; Cariou M; Kermarrec M; Kermarrec T; Bouzeloc S; Nousbaum JB; Robaszkiewicz M; Quénéhervé L
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101950. PubMed ID: 35609825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of recommendations for radiotherapy from two contemporaneous thoracic multidisciplinary meeting formats: co-located and video conference.
    Stevens G; Loh J; Kolbe J; Stevens W; Elder C
    Intern Med J; 2012 Nov; 42(11):1213-8. PubMed ID: 22530597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing patterns of care for pancreas cancer in Victoria: the 2022 Pancreas Tumour Summit.
    Pilgrim CHC; Finn N; Stuart E; Philip J; Steel S; Croagh D; Lee B; Tebbutt NC
    ANZ J Surg; 2023 Nov; 93(11):2638-2647. PubMed ID: 37221964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study.
    Rodríguez-Barranco M; Salamanca-Fernández E; Fajardo ML; Bayo E; Chang-Chan YL; Expósito J; García C; Tallón J; Minicozzi P; Sant M; Petrova D; Luque-Fernandez MA; Sánchez MJ
    Clin Transl Oncol; 2019 May; 21(5):621-629. PubMed ID: 30341474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated media presentation in multidisciplinary head and neck oncology meetings.
    Simo R; Morgan P; Jeannon JP; Odell E; Harrison J; Almeida B; McGurk M; Lyons A; Hussain K; Gleeson M; O'Connell M; Calman F; Ng R; Roblin P; Connor S; Fenlon M; Burke M; Chandra A; Herbert A; Patt S; Steward-Bagley L; Donnelly R; Freeman L; Twinn C; Mason C
    Eur Arch Otorhinolaryngol; 2009 Feb; 266(2):261-5. PubMed ID: 19057923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facilitating High Quality Cancer Care: A Qualitative Study of Australian Chairpersons' Perspectives on Multidisciplinary Team Meetings.
    Fradgley EA; Booth K; Paul C; Zdenkowski N; Rankin NM
    J Multidiscip Healthc; 2021; 14():3429-3439. PubMed ID: 34938082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.
    Feliciano J; Gardner L; Hendrick F; Edelman MJ; Davidoff A
    Lung Cancer; 2015 Jan; 87(1):59-64. PubMed ID: 25443272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities.
    Shin DW; Cho JH; Noh JM; Han H; Han K; Park SH; Kim SY; Park JH; Park JH; Kawachi I
    J Thorac Oncol; 2019 Feb; 14(2):163-175. PubMed ID: 30453082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study.
    Willén L; Berglund A; Bergström S; Bergqvist M; Öjdahl-Bodén A; Wagenius G; Lambe M
    Lung Cancer; 2019 May; 131():40-46. PubMed ID: 31027696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
    Bortot L; Targato G; Noto C; Giavarra M; Palmero L; Zara D; Bertoli E; Dri A; Andreetta C; Pascoletti G; Poletto E; Russo S; Seriau L; Mansutti M; Cedolini C; Basile D; Fasola G; Bonotto M; Minisini AM
    Front Oncol; 2022; 12():885992. PubMed ID: 35747814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Qualitative assessment of the multidisciplinary tumor board in breast cancer].
    Nguyen TD; Legrand P; Devie I; Cauchois A; Eymard JC
    Bull Cancer; 2008 Feb; 95(2):247-51. PubMed ID: 18304908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
    Kim YJ; Kim MJ; Cho YJ; Park JS; Kim JW; Chang H; Lee JO; Lee KW; Kim JH; Yoon HI; Bang SM; Lee JH; Lee CT; Lee JS
    Med Oncol; 2014 Mar; 31(3):847. PubMed ID: 24448977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The educational value of the multi-disciplinary meeting (MDM) in surgical oncology: A systematic review and thematic content analysis.
    Temperley H; Waters C; Larkins K; Murray C; O'Sullivan NJ; Mockler D; Humm G; Norden C; Phoenix E; Donohoe CL; Warrier S; Mohan H
    Eur J Surg Oncol; 2022 May; 48(5):935-945. PubMed ID: 35282975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?
    Baldotto CS; Cronemberger EH; de Biasi P; Zamboni M; Sousa A; Zukin M; Small IA; Ferreira CG
    Support Care Cancer; 2012 Nov; 20(11):2721-7. PubMed ID: 22322592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.